Related Experiment Video

Updated: Jun 6, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Biological Therapeutics Research and Development--GTCbio's Fifth Annual Conference. October 20-22, 2010, San

Hideki Garren1

  • 1Bayhill Therapeutics, 1804 Embarcadero Road, Suite 201, Palo Alto, CA 94303, USA. hgarren@bayhilltx.com

Idrugs : the Investigational Drugs Journal
|December 15, 2010
PubMed

Insights

This conference highlights advancements in biological therapeutics, focusing on novel vaccines and peptide therapies for cancer and autoimmune diseases. Key developments include DNA vaccines and combination therapies, with specific investigational drugs mentioned.

Area of Science:

  • Biotechnology and Pharmaceutical Sciences
  • Immunology and Vaccine Development
  • Therapeutic Drug Discovery

Background:

  • The Fifth Annual Conference on Biological Therapeutics Research and Development convened to discuss cutting-edge therapeutic advancements.
  • Focus areas included novel vaccine strategies and peptide-based therapeutics for various diseases.

Framework:

  • Presentations covered DNA delivery platforms for vaccine development.
  • Exploration of vaccine combination therapy for oncological applications.
  • Discussion on DNA vaccines tailored for autoimmune conditions.

Implementation:

  • Investigational drugs such as TG-4010 (Transgene) for non-small cell lung cancer (NSCLC) were reviewed.
  • Development of specific vaccines for autoimmune diseases including type I diabetes (BHT-3021), multiple sclerosis (BHT-3009), and myasthenia gravis (BHT-3034) was detailed.

Implications:

  • The conference underscored the potential of innovative vaccines and peptide therapeutics in clinical practice.
  • Advancements discussed offer new avenues for treating cancer and debilitating autoimmune disorders.
  • The development pipeline includes promising candidates for diverse therapeutic needs.

More Related Videos

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics08:29

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Related Concept Videos

Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...